Inari Medical, Inc. (NARI) Misses Q4 EPS by 1c

Inari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $78.16 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Investing.com’s stocks of the week
• BMO starts chip stocks coverage: Here are its preferred picks